Biotech · Public company · San Carlos, CA, US
Biomea Fusion, Inc.
Ticker BMEA · SEC CIK 0001840439
Track this companyFree. Adds Biomea Fusion, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials92 recruiting or active
Pipeline programs10From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availableNo recent cash burn filed
Pipeline10
- BMF-219Phase 2 · Type 2 Diabetes MellitusClinicalTrials.gov · fetched Nov 12, 2026
- BMF-219Phase 2 · Type 1 Diabetes MellitusClinicalTrials.gov · fetched Nov 12, 2026
- icovamenib 100 mgPhase 2 · Type 2 DiabetesClinicalTrials.gov · fetched Nov 12, 2026
- icovamenib 100mgPhase 2 · Type 2 DiabetesClinicalTrials.gov · fetched Nov 12, 2026
- BMF-219Phase 1 · Acute Myeloid LeukemiaClinicalTrials.gov · fetched Nov 12, 2026
- BMF-219Phase 1 · Non Small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
- BMF-500Phase 1 · Acute Myeloid LeukemiaClinicalTrials.gov · fetched Nov 12, 2026
- BMF-650Phase 1 · ObesityClinicalTrials.gov · fetched Nov 12, 2026
- IcovamenibPhase 1 · Healthy VolunteerClinicalTrials.gov · fetched Nov 12, 2026
- Icovamenib HPMCPhase 1 · Healthy VolunteerClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials9
- Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based TherapyPHASE2 · RECRUITING · started Apr 30, 2026ClinicalTrials.gov NCT07502508 · fetched Nov 12, 2026
- Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Who Are Not Achieving Glycemic TargetsPHASE2 · ACTIVE_NOT_RECRUITING · started Mar 27, 2026ClinicalTrials.gov NCT07502495 · fetched Nov 12, 2026
- Study of BMF-650 in Otherwise Healthy Overweight or Obese Adult ParticipantsPHASE1 · COMPLETED · started Oct 23, 2025ClinicalTrials.gov NCT07223216 · fetched Nov 12, 2026
- Food Effect Study in Healthy VolunteersPHASE1 · COMPLETED · started Sep 11, 2025ClinicalTrials.gov NCT07254286 · fetched Nov 12, 2026
- Phase 2 Trial of BMF-219 in Participants With Type 1 Diabetes MellitusPHASE2 · COMPLETED · started Dec 28, 2023ClinicalTrials.gov NCT06152042 · fetched Nov 12, 2026
- A Phase 1 Study of BMF-500 in Adults With Acute LeukemiaPHASE1 · COMPLETED · started Jul 26, 2023ClinicalTrials.gov NCT05918692 · fetched Nov 12, 2026
- Study of Covalent Menin Inhibitor BMF-219 in Adult Patients With KRAS Driven Non-Small Cell Lung Cancer, Pancreatic Cancer, and Colorectal CancerPHASE1 · TERMINATED · started Jan 12, 2023ClinicalTrials.gov NCT05631574 · fetched Nov 12, 2026
- Study of BMF-219 in Healthy Adult Subjects and in Adult Subjects With Type 2 Diabetes Mellitus (T2D)PHASE1_PHASE2 · COMPLETED · started Aug 17, 2022ClinicalTrials.gov NCT05731544 · fetched Nov 12, 2026
- Study of BMF-219, a Covalent Menin Inhibitor, in Adult Patients With AML, ALL (With KMT2A/ MLL1r, NPM1 Mutations), DLBCL, MM, and CLL/SLLPHASE1 · TERMINATED · started Jan 24, 2022ClinicalTrials.gov NCT05153330 · fetched Nov 12, 2026
SEC filings12
- 10-Q · 10-QSEC EDGAR · filed Nov 10, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Nov 10, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Oct 14, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Sep 22, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed Aug 5, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Aug 5, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jun 11, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed May 11, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed May 11, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Apr 28, 2026 · fetched Nov 12, 2026
- 10-K · 10-KSEC EDGAR · filed Mar 24, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Mar 24, 2026 · fetched Nov 12, 2026